Effect of Soluble CD39 and PD-L1 Levels on Diagnosis and Prognosis of Lung Cancer Patients with Malignant Pleural Effusion

被引：0
|
作者：
Chen, M. [1 ]
Li, X. [2 ]
Wan, B. [1 ]
Zhu, S. [2 ]
Chen, C. [1 ]
Zhang, F. [2 ]
Song, Y. [3 ]
Lv, T. [2 ]
机构：
[1] Southern Med Univ, Sch Clin Med 1, Jinling Hosp, Dept Resp Med, Guangzhou, Peoples R China
[2] Nanjing Univ, Sch Med, Jinling Hosp, Dept Resp & Crit Care Med, Nanjing, Peoples R China
[3] Nanjing Univ, Sch Med, Jinling Hosp, Nanjing, Peoples R China
来源：
JOURNAL OF THORACIC ONCOLOGY | 2021年 / 16卷 / 03期
关键词：
Soluble PD-L1; Soluble CD39; malignant pleural effusion (MPE);
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
P36.08
引用
收藏
页码：S437 / S438
页数：2
相关论文
共 50 条
  • [41] PD-L1 gene expression in Japanese lung cancer patients
    Sasaki, Hidefumi
    Suzuki, Ayumi
    Shitara, Masayuki
    Hikosaka, Yu
    Okuda, Katsuhiro
    Moriyama, Satoru
    Yano, Motoki
    Fujii, Yoshitaka
    BIOMEDICAL REPORTS, 2013, 1 (01) : 93 - 96
  • [42] Soluble Levels of CD163, PD-L1, and IL-10 in Renal Cell Carcinoma Patients
    Davidsson, Sabina
    Huotilainen, Sofia
    Carlsson, Jessica
    Sundqvist, Pernilla
    DIAGNOSTICS, 2022, 12 (02)
  • [43] The effect of gender on the clinical outcome of PD-1/PD-L1 inhibitor in advanced lung cancer patients
    Wu, Bing
    Sun, Congcong
    Sun, Xiaoqin
    Li, Xue
    MEDICINE, 2023, 102 (34) : E34849
  • [44] Prognostic value of soluble PD-L1 and exosomal PD-L1 in advanced gastric cancer patients receiving systemic chemotherapy
    Shin, Kabsoo
    Kim, Joori
    Park, Se Jun
    Lee, Myung Ah
    Park, Jae Myung
    Choi, Myung-Gyu
    Kang, Donghoon
    Song, Kyo Young
    Lee, Han Hong
    Seo, Ho Seok
    Lee, Sung Hak
    Kim, Bohyun
    Kim, Okran
    Park, Juyeon
    Kang, Nahyeon
    Kim, In-Ho
    SCIENTIFIC REPORTS, 2023, 13 (01)
  • [45] Prognostic value of soluble PD-L1 and exosomal PD-L1 in advanced gastric cancer patients receiving systemic chemotherapy
    Kabsoo Shin
    Joori Kim
    Se Jun Park
    Myung Ah Lee
    Jae Myung Park
    Myung-Gyu Choi
    Donghoon Kang
    Kyo Young Song
    Han Hong Lee
    Ho Seok Seo
    Sung Hak Lee
    Bohyun Kim
    Okran Kim
    Juyeon Park
    Nahyeon Kang
    In-Ho Kim
    Scientific Reports, 13
  • [46] Malignant pleural effusion as a predictor of the efficacy of anti-PD-1 antibody in patients with non-small cell lung cancer
    Shibaki, Ryota
    Murakami, Shuji
    Shinno, Yuki
    Matsumoto, Yuji
    Goto, Yasushi
    Kanda, Shintaro
    Horinouchi, Hidehito
    Fujiwara, Yutaka
    Motoi, Noriko
    Yamamoto, Noboru
    Ohe, Yuichiro
    THORACIC CANCER, 2019, 10 (04) : 815 - 822
  • [47] PD-L1 lineage-specific quantification in malignant pleural effusions of lung adenocarcinoma by flow cytometry
    Yoon, Ju-Yoon
    Nayyar, Rakesh
    Quest, Graeme
    Pabedinskas, Dana
    Pal, Prodipto
    Tsao, Ming-Sound
    Schwock, Joerg
    Ko, Hyang-Mi
    LUNG CANCER, 2020, 148 : 55 - 61
  • [48] PD-L1+CD4+T cells and soluble PD-L1 as prognostic factors to anti-PD-1 immunotherapy in advanced non small cell lung cancer patients.
    Vetsika, EleniKyriaki
    Aggouraki, Despoina
    Lyristi, Zacharoula
    Koukos, Aristeidis
    Kourougkiaouri, Despoina
    Georgoulias, Vassilis
    Kotsakis, Athanasios
    JOURNAL OF CLINICAL ONCOLOGY, 2018, 36 (15)
  • [49] Sensitivity of a PD-L1-Analysis in Patients with non-small cell Lung Cancer (NSCLC) with Pleural Effusion
    Hagmeyer, L.
    Treml, M.
    Richter, K.
    Hekmat, K.
    Heldwein, M.
    Schaefer, S.
    Buettner, R.
    Randerath, W. J.
    PNEUMOLOGIE, 2020, 74 : S40 - S41
  • [50] CD163+tumor-associated macrophage is a prognostic biomarker and is associated with therapeutic effect on malignant pleural effusion of lung cancer patients
    Yang, Li
    Wang, Fei
    Wang, Liping
    Huang, Lan
    Wang, Jing
    Zhang, Bin
    Zhang, Yi
    ONCOTARGET, 2015, 6 (12) : 10592 - 10603
12345